Continuing trastuzumab beyond progression

Research output: Contribution to journalArticle

11 Citations (Scopus)
Original languageEnglish
Pages (from-to)1935-1937
Number of pages3
JournalJournal of Clinical Oncology
Volume27
Issue number12
DOIs
StatePublished - Apr 20 2009
Externally publishedYes

Fingerprint

ErbB-2 Receptor
Antineoplastic Agents
Disease Progression
Monoclonal Antibodies
Breast Neoplasms
Trastuzumab

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Continuing trastuzumab beyond progression. / Jahanzeb, Mohammad.

In: Journal of Clinical Oncology, Vol. 27, No. 12, 20.04.2009, p. 1935-1937.

Research output: Contribution to journalArticle

@article{9ff461847ae44c7080a9a47da3f8087f,
title = "Continuing trastuzumab beyond progression",
author = "Mohammad Jahanzeb",
year = "2009",
month = "4",
day = "20",
doi = "10.1200/JCO.2008.20.8215",
language = "English",
volume = "27",
pages = "1935--1937",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "12",

}

TY - JOUR

T1 - Continuing trastuzumab beyond progression

AU - Jahanzeb, Mohammad

PY - 2009/4/20

Y1 - 2009/4/20

UR - http://www.scopus.com/inward/record.url?scp=65349158268&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65349158268&partnerID=8YFLogxK

U2 - 10.1200/JCO.2008.20.8215

DO - 10.1200/JCO.2008.20.8215

M3 - Article

C2 - 19289613

AN - SCOPUS:65349158268

VL - 27

SP - 1935

EP - 1937

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 12

ER -